Screening algorithms for HBV, HCV, HIV and syphilis in an anatomical donation program

被引:2
|
作者
Valcke, Brecht [1 ]
Vercauteren, Koen [2 ]
Padalko, Elizaveta [3 ]
Verhofstede, Chris [4 ]
D'Herde, Katharina [1 ]
Willaert, Wouter [1 ]
机构
[1] Univ Ghent, Dept Human Struct & Repair, Corneel Heymanslaan 10, B-9000 Ghent, Belgium
[2] Inst Trop Med, Clin Virol Unit, Clin Reference Lab, Kronenburgstr 43, B-2000 Antwerp, Belgium
[3] Ghent Univ Hosp, Lab Med Microbiol, Corneel Heymanslaan 10, B-9000 Ghent, Belgium
[4] Univ Ghent, Dept Diagnost Sci, Aids Reference Lab, Corneel Heymanslaan 10, B-9000 Ghent, Belgium
关键词
Anatomy; Cadaver; Embalming; Hemolysis; Hepatitis B virus; Hepatitis C virus; Human immunodeficiency virus; HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-B; POSTMORTEM VIABILITY; TREPONEMA-PALLIDUM; BLOOD-SAMPLES; CADAVER; TRANSMISSION; PREVALENCE; SURVIVAL; DISCARDS;
D O I
10.1016/j.aanat.2021.151805
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Background: Users of anatomical donors are at risk of exposure to bloodborne pathogens. This study evaluated screening algorithms for hepatitis B and C virus, human immunodeficiency virus and Treponema pallidum during donor allocation and assessed the impact of postmortem time on hemolysis and how hemolysis affects test results and donor discard rate. Methods: From 2011 to 2018, demographic data of anatomical donors, time of postmortem blood sampling, presence of sample hemolysis, serological test results (negative; active infection; false reactive screening test; historic infection; inconclusive; technically impracticable) and the actual donor allocation were collected. Results: Donors (n = 537) had a mean age of 77.53 +/- 13.67 (24-103) year. Nine (1.68%) had laboratory test results indicative for active infection for hepatitis B (n = 1) and C virus (n = 2), human immunodeficiency virus (n = 5) and T. pallidum (n = 1). Negative screenings ranged from 74.67 to 97.58%, depending on the pathogen. According to the original screening algorithms, 479 (89.20%) donors should have been accepted. In practice, a donor acceptance rate of 91.20% was found. Analysis of potential donor allocation interpretation obstacles resulted in simplification of the in-house laboratory testing algorithms and addition of a nucleic acid test to increase the reliability for identification of active (acute) human immunodeficiency virus infection. Hemolysis was more common when sampling was performed more than 24 h after death (p < 0.001). Hemolytic samples more frequently showed a reactive or indeterminate human immunodeficiency virus test result (p < 0.001). Screening for human immunodeficiency virus and T. pallidum was technically more impracticable when hemolysis was present (p = 0.042 and p = 0.003, respectively). Donors with hemolytic blood samples were more often discarded (46.88%) compared to bodies with non-hemolytic samples (6.32%) (p < 0.001). Conclusions: Despite the implementation of donor screening algorithms, a significant number of bodies have an inconsistent allocation. New algorithms, to be evaluated in future research, were suggested. Early postmortem blood sampling is key as hemolysis can influence certain test results and donor allocation. (c) 2021 Elsevier GmbH. All rights reserved.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Managing sharps injuries and other occupational exposures to HIV, HBV, and HCV in the dermatology office
    Brewer, Jerry D.
    Elston, Dirk M.
    Vidimos, Allison T.
    Rizza, Stacey A.
    Miller, Stanley J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (05) : 946 - +
  • [42] Co-Infection Assessment in HBV, HCV, and HIV Patients in Western Saudi Arabia
    Al-Mughales, Jamil A.
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (09) : 1545 - 1551
  • [43] EFFECT OF HIV PREVENTION AND TREATMENT PROGRAM ON HIV AND HCV TRANSMISSION AND HIV MORTALITY AT AN INDONESIAN NARCOTIC PRISON
    Nelwan, Erni J.
    Indrati, Agnes K.
    Isa, Ahmad
    Triani, Nurlita
    Alam, Nisaa Nur
    Herlan, Maria S.
    Husen, Wahid
    Pohan, Herdiman T.
    Alisjahbana, Bachti
    Meheus, Andre
    Van Crevel, Reinout
    van der Ven, Andre Jam
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2015, 46 (05) : 880 - 891
  • [44] Herne and HO-1 inhibition of HCV, HBV, and HIV
    Schmidt, Warren N.
    Mathahs, M. Meleah
    Zhu, Zhaowen
    FRONTIERS IN PHARMACOLOGY, 2012, 3
  • [45] Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study
    Andrew A Adjei
    Henry B Armah
    Foster Gbagbo
    William K Ampofo
    Isaac Boamah
    Clement Adu-Gyamfi
    Isaac Asare
    Ian FA Hesse
    George Mensah
    BMC Infectious Diseases, 8
  • [46] Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation
    Okoroiwu, Henshaw Uchechi
    Okafor, Ifeyinwa Maryann
    Asemota, Enosakhare Aiyudubie
    Okpokam, Dorathy Chioma
    BMC PUBLIC HEALTH, 2018, 18
  • [47] Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 2016
    Dodd, Roger Y.
    Crowder, Lauren A.
    Haynes, James M.
    Notari, Edward P.
    Stramer, Susan L.
    Steele, Whitney R.
    TRANSFUSION MEDICINE REVIEWS, 2020, 34 (02) : 81 - 93
  • [48] Sero-epidemiology and associated factors of HIV, HBV, HCV and syphilis among blood donors in Ethiopia: a systematic review and meta-analysis
    Melku, Mulugeta
    Ambachew, Sintayehu
    Enawgaw, Bamlaku
    Abebe, Molla
    Abebe, Zegeye
    Deressa, Tekalign
    Damtie, Debasu
    Biadgo, Belete
    Tessema, Belay
    Geremew, Demeke
    Kebede, Asemarie
    Woldu, Berhanu
    Teklu, Takele
    Shiferaw, Elias
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [49] HIV, HCV and HBV: A Review of Parallels and Differences
    Maria C. Leoni
    Andrew Ustianowski
    Hamzah Farooq
    Joop E. Arends
    Infectious Diseases and Therapy, 2018, 7 : 407 - 419
  • [50] HBV and HCV Coinfection in Patients Living with HIV
    Tekin, Suda
    Cinar, Gule
    Barkay, Orcun
    Celik, Ilhami
    KLIMIK JOURNAL, 2023, 36 (01) : 3 - 9